Legal Representation
Attorney
Charles T. J. Weigell
USPTO Deadlines
Next Deadline
1891 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20250225)
Due Date
February 25, 2031
Grace Period Ends
August 25, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
26 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 3, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Sep 13, 2025 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Sep 13, 2025 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Aug 1, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Jul 14, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Jul 14, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| May 25, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Feb 25, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Feb 25, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 7, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 7, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 1, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 14, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 13, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 13, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 13, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 28, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Jul 8, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Jul 8, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jun 18, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jun 17, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 7, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 28, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 24, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 23, 2024 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Feb 15, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; dietary supplements; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of osteoporosis; human vaccine preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; preparations for treatment of cancer; preparations for treatment of tumour diseases; preparations for treatment of multiple myeloma; pharmaceutical preparations for the treatment of skeletal diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of solid cancer
Classification
International Classes
005